A Chlamydia pneumoniae infection model using established human lymphocyte cell lines

FEMS Microbiology Letters

Volumn 216, Issue 2, 2002, Pages 229-234

  Yamaguchi, Hiroyuki ^a   Haranaga, Shusaku ^a   Friedman, Herman ^a   Moor, Jo A ^a   Muffly, Karl E ^a   Yamamoto, Yoshimasa ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Chlamydia pneumoniae; Established cell line; Infection model; Lymphocyte

Indexed keywords

BACTERIAL ANTIGEN;

ANTIGEN DETECTION; ARTICLE; BACTERIAL GROWTH; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; ELECTRON MICROSCOPY; EPITHELIUM CELL; HUMAN; HUMAN CELL; LYMPHOID CELL LINE; MODEL; MONOCYTE; NONHUMAN; PRIORITY JOURNAL;

CELL LINE; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LYMPHOCYTES; MICROSCOPY, ELECTRON; MICROSCOPY, FLUORESCENCE; MONOCYTES;

BACTERIA (MICROORGANISMS); CHLAMYDIA; CHLAMYDOPHILA PNEUMONIAE;

EID: 0037027544     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1097(02)01029-7     Document Type: Article

References (32)

1. Grayston J.T., Kuo C.C., Coulson A.S., Campbell L.A., Lawrence R.D., Lee M.J., Strandness E.D., Wang S.P. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation. 92:1995;3397-3400.
2. Ross R. Atherosclerosis - An inflammatory disease. N. Engl. J. Med. 340:1999;115-126.
3. Jonasson L., Holm J., Skalli O., Bondjers G., Hansson G.K. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis. 6:1986;131-138.
4. Watanabe T., Hirata M., Yoshikawa Y., Nagafuchi Y., Toyoshima H. Role of macrophages in atherosclerosis. Sequential observations of cholesterol-induced rabbit aortic lesion by the immunoperoxidase technique using monoclonal antimacrophage antibody. Lab. Invest. 53:1985;80-90.
5. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
6. Sullivan G.W., Sarembock I.J., Linden J. The role of inflammation in vascular diseases. J. Leukoc. Biol. 67:2000;591-602.
7. Airenne S., Surcel H.M., Alakarppa H., Laitinen K., Paavonen J., Saikku P., Laurila A. Chlamydia pneumoniae infection in human monocytes. Infect. Immun. 67:1999;1445-1449.
8. Gaydos C.A., Summersgill J.T., Sahney N.N., Ramirez J.A., Quinn T.C. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect. Immun. 64:1996;1614-1620.
9. Lin T.M., Campbell L.A., Rosenfeld M.E., Kuo C.C. Monocyte-endothelial cell coculture enhances infection of endothelial cells with Chlamydia pneumoniae. J. Infect. Dis. 181:2000;1096-1100.
10. Davidson M., Kuo C.C., Middaugh J.P., Campbell L.A., Wang S.P., Newman W.P. III, Finley J.C., Grayston J.T. Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis. Circulation. 98:1998;628-633.
11. Kaukoranta-Tolvanen S.S., Laitinen K., Saikku P., Leinonen M. Chlamydia pneumoniae multiplies in human endothelial cells in vitro. Microb. Pathog. 16:1994;313-319.
12. Quinn T.C., Gaydos C.A. In vitro infection and pathogenesis of Chlamydia pneumoniae in endovascular cells. Am. Heart J. 138:1999;S507-S511.
13. Haranaga S., Yamaguchi H., Friedman H., Izumi S., Yamamoto Y. Chlamydia pneumoniae infects and multiplies in lymphocytes in vitro. Infect. Immun. 69:2001;7753-7759.
14. Kaul R., Uphoff J., Wiedeman J., Yadlapalli S., Wenman W.M. Detection of Chlamydia pneumoniae DNA in CD3+ lymphocytes from healthy blood donors and patients with coronary artery disease. Circulation. 102:2000;2341-2346.
15. Hansson G.K. Immune mechanisms in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 21:2001;1876-1890.
16. Ossewaarde J.M., de Vries A., Bestebroer T., Angulo A.F. Application of a Mycoplasma group-specific PCR for monitoring decontamination of Mycoplasma-infected Chlamydia sp. strains. Appl. Environ. Microbiol. 62:1996;328-331.
17. Roblin P.M., Dumornay W., Hammerschlag M.R. Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae. J. Clin. Microbiol. 30:1992;1968-1971.
18. Summersgill J.T., Sahney N.N., Gaydos C.A., Quinn T.C., Ramirez J.A. Inhibition of Chlamydia pneumoniae growth in HEp-2 cells pretreated with gamma interferon and tumor necrosis factor alpha. Infect. Immun. 63:1995;2801-2803.
19. Den Beste H.E., Fjelde A., Jackson J.L., Andresen W.F., Kerr H.A., Evans V.J. Adaptation, growth, and chromosomal analysis of HEp-2 cells in chemically defined medium. J. Natl. Cancer Inst. 36:1966;1075-1088.
20. Mohamed A.M., Taye T., Akuffo H.O. Mechanisms of resistance to Leishmania aethiopica. I. Interferon-gamma in combination with a cytokine (not tumor necrosis factor-alpha) is required, but cannot act alone in the inhibition of intracellular forms of L. aethiopica in THP1 cells. Eur. J. Immunol. 22:1992;2331-2337.
21. Minowada J., Onuma T., Moore G.E. Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes. J. Natl. Cancer Inst. 49:1972;891-895.
22. Hinuma Y., Konn M., Yamaguchi J., Wudarski D.J., Blakeslee J.R. Jr., Grace J.T. Jr. Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line. J. Virol. 1:1967;1045-1051.
23. Miyashita N., Matsumoto A. Establishment of a particle-counting method for purified elementary bodies of chlamydiae and evaluation of sensitivities of the IDEIA Chlamydia kit and DNA probe by using the purified elementary bodies. J. Clin. Microbiol. 30:1992;2911-2916.
24. Klein T.W., Yamamoto Y., Brown H.K., Friedman H. Interferon-gamma induced resistance to Legionella pneumophila in susceptible A/J mouse macrophages. J. Leukoc. Biol. 49:1991;98-103.
25. Schenk H., Vogt M., Droge W., Schulze-Osthoff K. Thioredoxin as a potent costimulus of cytokine expression. J. Immunol. 156:1996;765-771.
26. Bacon K.B., et al. IL-8-induced signal transduction in T lymphocytes involves receptor-mediated activation of phospholipases C and D. J. Immunol. 154:1995;3654-3666.
27. Konikova E., Glasova M., Kusenda J., Babusikova O. Some early differentiation markers detected in cytoplasm of pre-B cells by flow cytometry. Neoplasma. 43:1996;373-379.
28. Kuo C.C., Grayston J.T. A sensitive cell line, HL cells, for isolation and propagation of Chlamydia pneumoniae strain TWAR. J. Infect. Dis. 162:1990;755-758.
29. Kutlin A., Flegg C., Stenzel D., Reznik T., Roblin P.M., Mathews S., Timms P., Hammerschlag M.R. Ultrastructural study of Chlamydia pneumoniae in a continuous-infection model. J. Clin. Microbiol. 39:2001;3721-3723.
30. Beatty W.L., Byrne G.I., Morrison R.P. Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro. Proc. Natl. Acad. Sci. USA. 90:1993;3998-4002.
31. Beatty W.L., Morrison R.P., Byrne G.I. Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol. Rev. 58:1994;686-699.
32. Kutlin A., Roblin P.M., Hammerschlag M.R. In vitro activities of azithromycin and ofloxacin against Chlamydia pneumoniae in a continuous-infection model. Antimicrob. Agents Chemother. 43:1999;2268-2272.